These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29217773)

  • 21. Dual Allosteric Inhibition of SHP2 Phosphatase.
    Fodor M; Price E; Wang P; Lu H; Argintaru A; Chen Z; Glick M; Hao HX; Kato M; Koenig R; LaRochelle JR; Liu G; McNeill E; Majumdar D; Nishiguchi GA; Perez LB; Paris G; Quinn CM; Ramsey T; Sendzik M; Shultz MD; Williams SL; Stams T; Blacklow SC; Acker MG; LaMarche MJ
    ACS Chem Biol; 2018 Mar; 13(3):647-656. PubMed ID: 29304282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine.
    Perni M; Flagmeier P; Limbocker R; Cascella R; Aprile FA; Galvagnion C; Heller GT; Meisl G; Chen SW; Kumita JR; Challa PK; Kirkegaard JB; Cohen SIA; Mannini B; Barbut D; Nollen EAA; Cecchi C; Cremades N; Knowles TPJ; Chiti F; Zasloff M; Vendruscolo M; Dobson CM
    ACS Chem Biol; 2018 Aug; 13(8):2308-2319. PubMed ID: 29953201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
    Eleftheriou P; Geronikaki A; Petrou A
    Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein tyrosine phosphatase 1B regulates endothelial endoplasmic reticulum stress; role in endothelial dysfunction.
    Thiebaut PA; Delile E; Coquerel D; Brunel JM; Renet S; Tamion F; Richard V
    Vascul Pharmacol; 2018 Oct; 109():36-44. PubMed ID: 29894845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2.
    Kostrzewa T; Sahu KK; Gorska-Ponikowska M; Tuszynski JA; Kuban-Jankowska A
    Drug Des Devel Ther; 2018; 12():4139-4147. PubMed ID: 30584278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice.
    Ito Y; Fukui M; Kanda M; Morishita K; Shoji Y; Kitao T; Hinoi E; Shirahase H
    J Pharmacol Sci; 2018 May; 137(1):38-46. PubMed ID: 29731242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018).
    Hussain H; Green IR; Abbas G; Adekenov SM; Hussain W; Ali I
    Expert Opin Ther Pat; 2019 Sep; 29(9):689-702. PubMed ID: 31402706
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway.
    Xu Q; Wu N; Li X; Guo C; Li C; Jiang B; Wang H; Shi D
    Cell Death Dis; 2019 Nov; 10(12):874. PubMed ID: 31745071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal Targeting of Hypothalamic PTP1B and TCPTP Reinstates Leptin and Insulin Sensitivity and Promotes Weight Loss in Obesity.
    Dodd GT; Xirouchaki CE; Eramo M; Mitchell CA; Andrews ZB; Henry BA; Cowley MA; Tiganis T
    Cell Rep; 2019 Sep; 28(11):2905-2922.e5. PubMed ID: 31509751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitors of Protein Tyrosine Phosphatase PTP1B With Anticancer Potential.
    Kostrzewa T; Styszko J; Gorska-Ponikowska M; Sledzinski T; Kuban-Jankowska A
    Anticancer Res; 2019 Jul; 39(7):3379-3384. PubMed ID: 31262859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of PTP1B activation through disruption of redox-complex formation.
    Londhe AD; Bergeron A; Curley SM; Zhang F; Rivera KD; Kannan A; Coulis G; Rizvi SHM; Kim SJ; Pappin DJ; Tonks NK; Linhardt RJ; Boivin B
    Nat Chem Biol; 2020 Feb; 16(2):122-125. PubMed ID: 31873221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Making biological membrane resistant to the toxicity of misfolded protein oligomers: a lesson from trodusquemine.
    Errico S; Lucchesi G; Odino D; Muscat S; Capitini C; Bugelli C; Canale C; Ferrando R; Grasso G; Barbut D; Calamai M; Danani A; Zasloff M; Relini A; Caminati G; Vendruscolo M; Chiti F
    Nanoscale; 2020 Nov; 12(44):22596-22614. PubMed ID: 33150350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism.
    Limbocker R; Mannini B; Ruggeri FS; Cascella R; Xu CK; Perni M; Chia S; Chen SW; Habchi J; Bigi A; Kreiser RP; Wright AK; Albright JA; Kartanas T; Kumita JR; Cremades N; Zasloff M; Cecchi C; Knowles TPJ; Chiti F; Vendruscolo M; Dobson CM
    Commun Biol; 2020 Aug; 3(1):435. PubMed ID: 32792544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
    Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening and identification of potential PTP1B allosteric inhibitors using in silico and in vitro approaches.
    Shinde RN; Kumar GS; Eqbal S; Sobhia ME
    PLoS One; 2018; 13(6):e0199020. PubMed ID: 29912965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired insulin signaling and spatial learning in middle-aged rats: The role of PTP1B.
    Kuga GK; Muñoz VR; Gaspar RC; Nakandakari SCBR; da Silva ASR; Botezelli JD; Leme JACA; Gomes RJ; de Moura LP; Cintra DE; Ropelle ER; Pauli JR
    Exp Gerontol; 2018 Apr; 104():66-71. PubMed ID: 29421605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advance on PTP1B inhibitors and their biomedical applications.
    Sharma B; Xie L; Yang F; Wang W; Zhou Q; Xiang M; Zhou S; Lv W; Jia Y; Pokhrel L; Shen J; Xiao Q; Gao L; Deng W
    Eur J Med Chem; 2020 Aug; 199():112376. PubMed ID: 32416458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Protein Tyrosine Phosphatase (PTP)-1B in Cardiovascular Disease and Its Interplay with Insulin Resistance.
    Abdelsalam SS; Korashy HM; Zeidan A; Agouni A
    Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31319588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies.
    Song Z; Wang M; Ge Y; Chen XP; Xu Z; Sun Y; Xiong XF
    Acta Pharm Sin B; 2021 Jan; 11(1):13-29. PubMed ID: 33532178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidiabetic activity in vitro and in vivo of BDB, a selective inhibitor of protein tyrosine phosphatase 1B, from Rhodomela confervoides.
    Luo J; Zheng M; Jiang B; Li C; Guo S; Wang L; Li X; Yu R; Shi D
    Br J Pharmacol; 2020 Oct; 177(19):4464-4480. PubMed ID: 32663313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.